2012
DOI: 10.1055/s-0032-1315006
|View full text |Cite
|
Sign up to set email alerts
|

Primary Malignant Vaginal Melanoma - Case Report and Review of the Literature

Abstract: With fewer than 250 cases published worldwide, primary vaginal melanoma is an extremely rare malignant entity which is mostly diagnosed in advanced stages. The estimated incidence of vaginal melanoma is 0.026/100?000 women per year. The poor prognosis for advanced tumour stages and different therapies used in very limited numbers of patients require precise preoperative staging and a planned interdisciplinary therapeutic approach.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
7
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(10 citation statements)
references
References 14 publications
3
7
0
Order By: Relevance
“…The histopathological findings in our patient are largely consistent with what has been reported in the literature as features commonly observed in primary melanoma of the vagina, namely, and in no particular order: an epithelioid morphology (which is the most common morphology, reported in more than half of the cases)9; an in situ component with an overlaying intact epithelium; cytological atypia and mitotic activity 13–15. Various markers of immunohistochemical staining have traditionally also been used to provide reliable confirmation of a diagnosis of primary vaginal melanoma, including protein S-100, T311, Mart-1, Melan A, HMB-45, tyrosinase and vimentin 5 7.…”
Section: Discussionsupporting
confidence: 89%
See 1 more Smart Citation
“…The histopathological findings in our patient are largely consistent with what has been reported in the literature as features commonly observed in primary melanoma of the vagina, namely, and in no particular order: an epithelioid morphology (which is the most common morphology, reported in more than half of the cases)9; an in situ component with an overlaying intact epithelium; cytological atypia and mitotic activity 13–15. Various markers of immunohistochemical staining have traditionally also been used to provide reliable confirmation of a diagnosis of primary vaginal melanoma, including protein S-100, T311, Mart-1, Melan A, HMB-45, tyrosinase and vimentin 5 7.…”
Section: Discussionsupporting
confidence: 89%
“…Lymph node involvement, if any, significantly worsened the prognosis of patients 2 29. The reported rate of lymph node involvement or metastases ranges quite widely from as low as 8% to as high as 50% 3 14. Overall, the expected outcome of patients with primary malignant vaginal melanoma is poor.…”
Section: Discussionmentioning
confidence: 99%
“…The common sites of metastases are lungs, liver, bones, and brain. Tumor size is the most important prognostic factor [3][4][5]. The overall five-year survival rate for women with vaginal melanoma is only about 8-20% when compared to around 47% for women with melanoma of the vulva and 81% for women with cutaneous melanoma [2,6].…”
Section: Discussionmentioning
confidence: 99%
“…Primary vaginal malignant melanomas are rare and aggressive tumors. Only 500 cases have been reported [ 2 ], principally affecting postmenopausal women, with a mean age of 57 years [ 4 ]. Mucosal melanomas are more often associated with KIT gene mutations rather than BRAF mutations, which are more often found in cutaneous melanomas [ 5 ].…”
Section: Discussionmentioning
confidence: 99%